Presidio Property Trust, Inc. (SQFT) - Q1 2025 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2025. Presidio Property Trust, Inc. is an internally managed Real Estate Investment Trust (REIT) holding a diversified portfolio of office, industrial, retail, and triple-net leased model home properties. The company operates as a non-accelerated filer and smaller reporting company.
Key Financial Metrics
| Metric | Q1 2025 | Q1 2024 |
|---|---|---|
| Total Revenue | $4.13 million | $4.79 million |
| Net Income (Loss) Attributable to Common Stockholders | $1.69 million | ($5.76 million) |
| Net Operating Income (NOI) | $2.51 million | $3.23 million |
| Cash, Cash Equivalents, and Restricted Cash | $11.96 million | $8.04 million |
| Total Mortgage Notes Payable (Principal) | $94.44 million | $102.84 million |
| Weighted Average Interest Rate | 5.83% | 5.23% |
| Dividends Paid (Series D Preferred) | $0.58 million | $0.52 million |
Material Changes vs. Prior Period
- Profitability Turnaround: The company reported a net income of $1.69 million for common stockholders in Q1 2025, a significant improvement from a net loss of $5.76 million in Q1 2024. This shift was primarily driven by a $4.45 million gain on the sale of real estate (compared to $2.02 million in the prior year) and a reduced loss on Conduit Pharmaceuticals marketable securities ($0.18 million loss vs. $3.86 million loss).
- Revenue Decline: Total revenue decreased by approximately 14% to $4.13 million. This decline is attributed to the sale of two commercial properties (Union Town Center and Research Parkway) in February 2025 and a reduction in the average number of model homes held (81 in Q1 2025 vs. 99 in Q1 2024).
- Debt Reduction: Total mortgage debt decreased by approximately $8.4 million to $94.4 million, largely due to the payoff of loans associated with the sold commercial properties.
- Expense Management: General and Administrative (G&A) expenses decreased by approximately $0.4 million to $1.66 million, driven by lower consulting fees and reduced stock-based compensation.
Guidance, Outlook, and Risks
- Liquidity and Debt Maturities: Management expects to fund operations for the next 12 months through working capital, refinancing, and property sales. However, $27.8 million in principal payments are due in the remainder of 2025, and $18.4 million in 2026. Three commercial property loans totaling approximately $28.2 million mature within the next 12 months.
- Default Notice: The company received notice of a maturity date default on the Dakota Center loan (approx. $9.1 million principal) which matured on July 6, 2024. The property is classified as "held for sale" to settle the non-recourse debt. The company is accruing default interest and fees.
- Capital Allocation: The Board authorized a stock repurchase program (up to $6.0 million for Common Stock and $4.0 million for Preferred Stock) expiring in December 2025. In Q1 2025, the company repurchased 12,844 shares of Series D Preferred Stock for approximately $0.19 million. No Common Stock was repurchased in the quarter.
- Subsequent Events: In April and May 2025, the company completed a tender offer purchasing 2.14 million shares of Common Stock for approximately $1.46 million. Additionally, the company acquired five new model homes in Texas for $3.3 million and sold three model homes for $1.5 million.
- Risks: Key risks include the inability to refinance maturing debt on acceptable terms, potential delisting from Nasdaq if listing requirements are not met, and the impact of activist stockholder activities.
Investor Verification Checklist
- Debt Refinancing Status: Verify the progress on refinancing the three commercial loans maturing within 12 months ($28.2 million) and the resolution of the Dakota Center default.
- Model Home Portfolio Turnover: Assess the sustainability of the model home segment given the high turnover rate and the reliance on short-term triple-net leases.
- Conduit Pharmaceuticals Exposure: Monitor the valuation of the remaining investment in Conduit Pharmaceuticals (approx. $29,519) and the impact of the reverse stock split on future volatility.
- Dividend Sustainability: Confirm the ability to maintain monthly Series D Preferred dividends ($0.19531/share) given the current cash flow and debt service obligations.
- Occupancy Rates: Review occupancy levels for the Shea Center II property, where a major tenant (Halliburton) vacated in late 2022, and the progress of leasing the remaining 46% of the space.